GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML
Product details
Registration number: SIN15244P
Classification: Prescription Only
Active ingredients: Aminolevulinic acid 23.4mg/ml equivalent aminolevulinic acid hydrochloride
Strength: 30mg/ml
Dosage form: POWDER, FOR SOLUTION
Route: ORAL
Registrant: LINK HEALTHCARE SINGAPORE PTE LTD
ATC code: L01XD04
HSA approval date: 26 May 2017
Manufacturer(s): LyoContract GmBH
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15244P
Classification: Prescription Only
What active ingredients and strength are recorded for GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Aminolevulinic acid 23.4mg/ml equivalent aminolevulinic acid hydrochloride
Strength: 30mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: POWDER, FOR SOLUTION
Route: ORAL
Who is the recorded registrant for GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: LINK HEALTHCARE SINGAPORE PTE LTD
Which manufacturers and countries are listed for GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): LyoContract GmBH
Manufacturing country/countries: GERMANY
Where can I look up GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15244P or the exact product name GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML. The general register link does not preselect this product.
What are the source dates for this GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15244P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)